Hinge Health, Inc.
NYSE:HNGEMedical - Healthcare Information Services
-$0.24 today
- Market cap
- $9.31B
- Beta
- 1.99
- P/E (TTM)
- -10.3
- EPS (TTM)
- -$6.49
Volume 1.23M
Average 1.34M
HNGE Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
Hinge Health, Inc.NYSE: HNGE
Operating Expenses · Q2 FY2026 · quarter ended Jun 2026
Operating expenses declines year over year
Q2 FY2026 operating expenses of $143.51M fell 78.8% year over year, behind the -44.3% change in trailing-twelve-month operating expenses. Sequentially, it rose 17.5% from the prior quarter.
Context
- Operating expenses amounted to 172.8% of revenue in FY2025, up 87.6 pp from a year earlier.
- Operating expenses increased in 2 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether quarterly growth recovers from -78.8% toward the trailing-twelve-month pace of -44.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
USD · from the income statement
- Latest · FY2025
- 1.02B USD
- Year-over-year change
- +205.5%
- 2-year CAGR
- +76.9%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.02B | +205.5% |
| FY2024 | 2024-12-31 | 332.5M | +2.4% |
| FY2023 | 2023-12-31 | 324.69M | — |
Operating Expenses vs competitors
How HNGE compares with its peers on the latest reported figures
- HNGE's LTM Jun 2026 operating expenses of $514.92M is the 3rd highest of the 5 companies compared; the peer median is $714.45M.
- Its year-over-year change of -44.3% is the lowest of 5, against a peer median of -1.3%.
- Operating expenses amounts to 71.5% of revenue for HNGE, versus a peer median of 54.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2025 | $3.41B | -0.3% | +1.6% | 55.4% | |
| LTM Apr 2026 | $1.23B | -38.3% | +13.2% | 54.1% | |
| LTM Jun 2026 | $514.92M | -44.3% | — | 71.5% | |
| LTM Mar 2026 | $195.96M | +29.8% | +16.7% | 69.2% | |
| LTM Mar 2026 | $61.83M | -2.3% | +11.7% | 8.5% | |
| Peer median (excluding HNGE) | $714.45M | -1.3% | +12.4% | 54.7% | |
Competitors are the stored peer set for HNGE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Revenue | 292.73M | 390.4M | 587.86M |
| Cost of Revenue | 98.55M | 89.81M | 118.56M |
| Gross Profit | 194.18M | 300.59M | 469.3M |
| Gross Margin | 66.3% | 77.0% | 79.8% |
| Research & Development | 110.06M | 100.84M | 368.14M |
| Selling, General & Admin | 214.64M | 227.54M | 639.41M |
| Operating Expenses | 324.69M | 332.5M | 1.02B |
| Depreciation & Amortization | 5.63M | 5.95M | 5.13M |
| EBITDA | (124.89M) | (18.48M) | (535.89M) |
| EBITDA Margin | -42.7% | -4.7% | -91.2% |
| Operating Income | (130.51M) | (31.91M) | (546.37M) |
| Operating Margin | -44.6% | -8.2% | -92.9% |
| Interest Income | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 |
| Other Income / Expenses | 21.97M | 20.65M | 19.11M |
| Income Before Tax | (108.55M) | (11.26M) | (527.26M) |
| Pre-Tax Margin | -37.1% | -2.9% | -89.7% |
| Income Tax Expense | (405K) | 677K | 998K |
| Net Income | (108.14M) | (11.93M) | (528.26M) |
| Net Margin | -36.9% | -3.1% | -89.9% |
| EPS (Basic) | (1.39) | (0.15) | (5.36) |
| EPS (Diluted) | (1.39) | (0.15) | (5.19) |
| Weighted Avg Shares | 78.02M | 78.02M | 79.19M |
| Weighted Avg Shares (Diluted) | 78.02M | 78.02M | 81.7M |
Hinge Health, Inc.
NYSE:HNGE
Intrinsic Alpha fair value
Locked
Current Price
$114.53
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.